Muscle-specific effects of hindlimb suspension and clenbuterol in mature male rats

Cells Tissues Organs

Volumn 171, Issue 2-3, 2002, Pages 188-198

  Wineski, Lawrence E ^a   Von Deutsch, Daniel A ^a   Abukhalaf, Imad K ^a   Pitts, Sidney A ^a   Potter, David E ^a   Paulsen, Douglas F ^a  

^a MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Beta adrenergic agonists; Microgravity; Muscle atrophy; Proteins; Rat; Unloading

Indexed keywords

CLENBUTEROL; DRUG VEHICLE; MUSCLE PROTEIN; PROTEIN; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; EXTENSOR DIGITORUM LONGUS MUSCLE; HINDLIMB; IMMOBILIZATION; LEG MUSCLE; LOADING TEST; MALE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE HYPERTROPHY; MUSCLE MASS; NONHUMAN; PLANTARIS MUSCLE; PREDICTION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; RAT; RELIABILITY; SOLEUS MUSCLE; ANIMAL; HUMAN; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZATION; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ADRENERGIC BETA-AGONISTS; ANIMAL; CLENBUTEROL; HINDLIMB SUSPENSION; HUMAN; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; ANIMALS; HUMANS;

EID: 0036020389     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063712     Document Type: Article

References (74)

1. Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA
2. Effect of short term unweighting on human skeletal muscle size and strength
3. Effect of clenbuterol on normal and denervated muscle growth and contractility
4. A trial of clenbuterol in bronchial asthma
5. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats
6. α-Actin and cytochrome c mRNAs in atrophied adult rat skeletal muscle
7. Clenbuterol prevents or inhibits loss of specific mRNAs in atrophying rat skeletal muscle
8. Plasticity in skeletal, cardiac, and smooth muscle. Invited review: Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle
9. Action and interaction of growth hormone and the beta-agonist, clenbuterol, on growth, body composition and protein turnover in dwarf mice
10. Clenbuterol and sport
11. Effects of clenbuterol on skeletal muscle mass, body composition, and recovery from surgical stress in senescent rats
12. Effects of clenbuterol on recovery of muscle mass and carcass protein following experimental hyperthyroidism in old rats
13. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats
14. Arterial morphology and blood volumes of rats following 10-14 weeks of tail suspension
15. 2-adrenoceptor activation
16. Changes in volume, muscle compartment, and compliance of the lower extremities in man following 30 days of exposure to simulated microgravity
17. Clenbuterol-induced fiber-type transition in soleus of adult rats
18. Overexpression of IGF-1 in skeletal muscle of transgenic mice does not prevent unloading-induced atrophy
19. Rat hind-limb muscle blood flow during level and downhill locomotion
20. Myogenic and vasoconstrictor responsiveness of skeletal muscle arterioles is diminished by hind-limb unloading
21. Pharmacokinetic/pharmacodynamic consequences of space flight
22. Contractile and biochemical properties of rat soleus and plantaris after hind-limb suspension
23. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle
24. Small animal model of weightlessness for pharmacokinetic evaluation
25. Prolonged bedrest decreases skeletal muscle and whole body protein synthesis
26. Physiology of a microgravity environment (invited review): Microgravity and skeletal muscle
27. Growth hormone and insulin-like growth factor system in myogenesis
28. Effects on meat quality of the use of clenbuterol in veal calves
29. Beta-2-adrenoceptor agonist-induced down-regulation after short-term exposure
30. Elevated interstitial fluid volume in rat soleus muscles by hind-limb unweighting
31. Illegal use of beta-adrenergic agonists: European Community
32. Muscle strength and speed of movement in relation to age and muscle morphology
33. Anabolic influences of insulin-like growth factor I and/or growth hormone on the diaphragm of young rats
34. The effect of the growth-promoting drug, clenbuterol on fibre frequency and area in hind limb muscles from young male rats
35. Inhibition and reversal of denervation-induced atrophy by the β-agonist growth promoter clenbuterol
36. Clenbuterol, a beta agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms
37. Fiber-type composition of nine rat muscles. I. Changes during the first year of life
38. The effect of clenbuterol administration in utero and through-out lactation on pre- and post-natal muscle development in the rat
39. Clenbuterol, a β-adrenoreceptor agonist, increases relative muscle strength in orthopedic patients
40. Effect of protease inhibitors and clenbuterol on the in vitro degradation of dystrophin by endogenous proteases in human skeletal muscle
41. Influence of spaceflight on rat skeletal muscle
42. Illegal use of beta-adrenergic agonists in the United States
43. Hind-limb unloading of growing rats: A model for predicting skeletal changes during space flight
44. Weightlessness simulations for cardiovascular and muscle systems: Validity of rat models
45. Clenbuterol: A medal in tablet form?
46. Mammalian skeletal muscle fiber type transitions
47. Clenbuterol: A substitute for anabolic steroids?
48. Role of nitric oxide in skeletal muscle: Synthesis, distribution and functional importance
49. Hypogravity induced atrophy of rat soleus and extensor digitorum longus muscles
50. Rat hind-limb unloading: Soleus histochemistry, ultrastructure, and electromyography
51. Skeletal muscle fiber, nerve, and blood vessel breakdown in space-flown rats
52. In-flight and postflight changes in skeletal muscles of SLS-1 and SLS-2 space-flown rats
53. Recruitment patterns in the rat hind-limb muscle during swimming
54. IGF-I, growth hormone and/or exercise effects on non-weight-bearing-soleus of hypophysectomized rats
55. Pharmacology in space: Pharmacokinetics
56. Molecular diversity of myofibrillar proteins: Gene regulation and functional significance
57. Insulin resistance for glucose metabolism in disused soleus muscle of mice
58. Measurement of protein using bicinchocinic acid
59. Age effects on rat hind-limb muscle atrophy during suspension unloading
60. Muscle adaptations to hind-limb suspension in mature and old Fischer 344 rats
61. Five myofibrillar lesion types in eccentrically challenged, unloaded rat adductor longus muscle: A test model
62. Single soleus muscle fiber function after hind-limb unweighting in adult and aged rats
63. Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle
64. Nitric-oxide synthase is a mechanical signal transducer that modulates talin and vinculin expression
65. Effect of anabolic steroids on skeletal muscle mass during hind-limb suspension
66. β-Agonist-induced alterations in organ weights and protein content: Comparison of racemic clenbuterol and its enantiomers
67. Distribution and muscle-sparing effects of clenbuterol in hindlimb suspended rats
68. Muscle-specific effects of clenbuterol on protein density and wet weight in soleus and plantaris muscles of mature, hindlimb-suspended rats
69. Anabolic-androgenic steroids: Current issues
70. Clenbuterol, a β2-agonist, retards atrophy in denervated muscles
71. Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a β2-receptor agonist